Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=14 Randomized Treatment

Effects of Exercise Training on Fluid Instability in Heart Failure Patients

Heart Failure

Bottom Line

View on ClinicalTrials.gov: NCT01375673 ↗
Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Jun 2020
Primary outcome: Primary: Bioelectrical Impedance Change — 47.52; 47.1; 41.27; 46.8 Percentage of Extra Cellular Fluid

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Exercise (Other)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Aug 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Bioelectrical Impedance Change		 47.52; 47.1; 41.27; 46.8; 42.1; 47.0 —
SECONDARY
Body Weight Change		 249; 256; 242; 260; 258; 261 —
SECONDARY
Health Outcome Measures Change		 25.05; 27.25; 18.2; 28.25; 28.55; 29.5 —

Summary

Heart Failure (HF) is a significant healthcare concern in the US, with a 120% rise in mortality rates over 15 years costing the country an estimated $37.2 billion in 2009. Veterans are currently impacted at a rate of 5.2%, and cost an average of $14,959/individual/year for those utilizing the VA's Healthcare services. Research has shown that exercise training (ET) improves aerobic capacity, endothelial dysfunction, quality of life, and the ability to tolerate activity within the overall HF population. The purpose of this study is to examine the effects of structured exercise training and specific types of exercise training, walking, bicycling, and resistance training, on the symptom of fluid volume over load or edema in advanced heart failure patients.

Eligibility Criteria

Inclusion Criteria

  • Advanced Heart Failure
  • Ability to Walk
  • Over 21

Exclusion Criteria

  • Renal Failure
  • Inability to walk
  • Physician exclusion
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01375673). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search